NCT02562131View on ClinicalTrials.gov

PET-MR-PSA Prostate Cancer Recidive Study

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Prostate Cancer Recurrent
Trial Locations (1)

7006

St Olavs Hospital, PET center, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT02562131 - PET-MR-PSA Prostate Cancer Recidive Study | Biotech Hunter | Biotech Hunter